ARMISTICE CAPITAL, LLC - Q3 2018 holdings

$1.67 Billion is the total value of ARMISTICE CAPITAL, LLC's 77 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 71.2% .

 Value Shares↓ Weighting
SPY SellSPDR S&P 500 ETF TRput$197,690,000
+1.2%
680,000
-5.6%
11.87%
-7.0%
CERC BuyCERECOR INC$81,727,000
+14.7%
17,500,400
+6.6%
4.91%
+5.5%
CPB BuyCAMPBELL SOUP COcall$73,260,000
+77.2%
2,000,000
+96.1%
4.40%
+62.9%
CAKE BuyCHEESECAKE FACTORY INCcall$58,894,000
+105.7%
1,100,000
+111.5%
3.54%
+89.0%
HAIN BuyHAIN CELESTIAL GROUP INCcall$54,240,000
+127.5%
2,000,000
+150.0%
3.26%
+109.1%
SJM BuySMUCKER J M CO$52,947,000
+52.0%
516,000
+59.3%
3.18%
+39.8%
INCY NewINCYTE CORPcall$48,356,000700,000
+100.0%
2.90%
CLVS BuyCLOVIS ONCOLOGY INC$48,049,000
+69.3%
1,636,000
+162.2%
2.88%
+55.6%
EPC SellEDGEWELL PERS CARE CO$46,230,000
-16.1%
1,000,000
-8.4%
2.78%
-22.9%
MNKKQ SellMALLINCKRODT PUB LTD CO$45,137,000
+0.8%
1,540,000
-35.8%
2.71%
-7.4%
AMAG  AMAG PHARMACEUTICALS INC$41,600,000
+2.6%
2,080,0000.0%2.50%
-5.7%
ENTA BuyENANTA PHARMACEUTICALS INC$38,970,000
+171.2%
456,000
+267.7%
2.34%
+149.4%
PGNX BuyPROGENICS PHARMACEUTICALS IN$38,611,000
+89.4%
6,158,000
+142.8%
2.32%
+74.2%
UTHR NewUNITED THERAPEUTICS CORP DEL$37,341,000292,000
+100.0%
2.24%
HOG SellHARLEY DAVIDSON INC$37,327,000
-11.3%
824,000
-17.6%
2.24%
-18.4%
HBI BuyHANESBRANDS INC$36,860,000
+30.8%
2,000,000
+56.2%
2.21%
+20.2%
KORS BuyMICHAEL KORS HLDGS LTD$36,748,000
+32.0%
536,000
+28.2%
2.21%
+21.3%
VYGR BuyVOYAGER THERAPEUTICS INC$32,618,000
+286.4%
1,724,000
+299.1%
1.96%
+255.4%
PLYA BuyPLAYA HOTELS & RESORTS NV$32,280,000
+1.8%
3,352,000
+14.2%
1.94%
-6.4%
CAR NewAVIS BUDGET GROUP$32,140,0001,000,000
+100.0%
1.93%
DFRG BuyDEL FRISCOS RESTAURANT GROUP$31,175,000
+147.4%
3,756,000
+275.6%
1.87%
+127.3%
ATRS SellANTARES PHARMA INC$30,643,000
-1.4%
9,120,000
-24.3%
1.84%
-9.4%
REGN SellREGENERON PHARMACEUTICALS$30,303,000
-31.4%
75,000
-41.4%
1.82%
-36.9%
RL NewRALPH LAUREN CORPcl a$29,986,000218,000
+100.0%
1.80%
HAIN NewHAIN CELESTIAL GROUP INC$27,120,0001,000,000
+100.0%
1.63%
DESP SellDESPEGAR COM CORP$26,385,000
-21.0%
1,564,000
-1.8%
1.58%
-27.3%
SGMS BuySCIENTIFIC GAMES CORP$22,860,000
+26.4%
900,000
+144.6%
1.37%
+16.2%
VNDA SellVANDA PHARMACEUTICALS INC$20,655,000
-51.2%
900,000
-59.5%
1.24%
-55.2%
QRTEA BuyQURATE RETAIL INC$19,989,000
+92.2%
900,000
+83.7%
1.20%
+76.7%
ASRT NewASSERTIO THERAPEUTICS INC$17,640,0003,000,000
+100.0%
1.06%
PETS NewPETMED EXPRESS INC$17,561,000532,000
+100.0%
1.05%
MDGL NewMADRIGAL PHARMACEUTICALS INC$17,130,00080,000
+100.0%
1.03%
CLLS NewCELLECTIS S Asponsored ads$16,932,000600,000
+100.0%
1.02%
BBY BuyBEST BUY INC$15,872,000
+52.0%
200,000
+42.9%
0.95%
+39.7%
GPS SellGAP INC DEL$15,117,000
-45.7%
524,000
-39.1%
0.91%
-50.1%
ZFGN SellZAFGEN INC$13,607,000
-11.3%
1,164,000
-22.4%
0.82%
-18.5%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$12,853,000
-0.7%
2,650,000
+22.8%
0.77%
-8.7%
BLUE SellBLUEBIRD BIO INC$12,848,000
-54.5%
88,000
-51.1%
0.77%
-58.2%
ONCE BuySPARK THERAPEUTICS INC$12,437,000
+0.2%
228,000
+52.0%
0.75%
-7.9%
RDUS NewRADIUS HEALTH INC$11,712,000658,000
+100.0%
0.70%
PRTK BuyPARATEK PHARMACEUTICALS INC$11,640,000
+0.8%
1,200,000
+6.0%
0.70%
-7.3%
ATEC BuyALPHATEC HOLDINGS INC$11,122,000
+15.5%
3,300,414
+2.2%
0.67%
+6.2%
 PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$9,531,000
+0.4%
21,760,0000.0%0.57%
-7.7%
EAT NewBRINKER INTL INC$9,346,000200,000
+100.0%
0.56%
BDSI BuyBIODELIVERY SCIENCES INTL IN$9,218,000
+2482.1%
3,292,000
+2623.2%
0.55%
+2304.3%
FND NewFLOOR & DECOR HLDGS INCcl a$9,051,000300,000
+100.0%
0.54%
FB BuyFACEBOOK INCcl a$8,223,000
+135.1%
50,000
+177.8%
0.49%
+116.7%
LULU NewLULULEMON ATHLETICA INC$8,125,00050,000
+100.0%
0.49%
CVS SellCVS HEALTH CORP$7,872,000
-75.5%
100,000
-80.0%
0.47%
-77.5%
SLDB SellSOLID BIOSCIENCES INC$7,738,000
+20.7%
164,000
-8.9%
0.46%
+10.7%
TLRDQ NewTAILORED BRANDS INC$7,557,000300,000
+100.0%
0.45%
ACHN SellACHILLION PHARMACEUTICALS IN$7,360,000
-35.0%
2,000,000
-50.0%
0.44%
-40.2%
ALIM  ALIMERA SCIENCES INC$6,797,000
+0.2%
6,936,0000.0%0.41%
-7.9%
CPRX SellCATALYST PHARMACEUTICALS INC$6,320,000
+19.2%
1,672,000
-1.6%
0.38%
+9.5%
VICL  VICAL INC$5,974,000
+19.1%
4,360,5000.0%0.36%
+9.8%
NVLNF  NOVELION THERAPEUTICS INC$5,494,000
-19.6%
1,856,0000.0%0.33%
-26.0%
FTCH NewFARFETCH LTDord sh cl a$5,446,000200,000
+100.0%
0.33%
MED NewMEDIFAST INC$5,317,00024,000
+100.0%
0.32%
TPX SellTEMPUR SEALY INTL INC$5,290,000
-87.1%
100,000
-88.3%
0.32%
-88.2%
EYEG  EYEGATE PHARMACEUTICALS INC$5,209,000
-41.5%
16,802,5000.0%0.31%
-46.1%
APRN NewBLUE APRON HLDGS INCcall$5,160,0003,000,000
+100.0%
0.31%
CMRX BuyCHIMERIX INC$5,057,000
-15.5%
1,300,000
+3.3%
0.30%
-22.3%
NAKD BuyNAKED BRAND GROUP LIMITED$4,917,000
-51.5%
1,828,000
+14.2%
0.30%
-55.4%
PDLI NewPDL BIOPHARMA INC$4,734,0001,800,000
+100.0%
0.28%
JCPNQ NewPENNEY J C INCcall$3,818,0002,300,000
+100.0%
0.23%
T NewAT&T INC$3,358,000100,000
+100.0%
0.20%
ORMP NewORAMED PHARM INC$3,039,000624,000
+100.0%
0.18%
IPCIF NewINTELLIPHARMACEUTICS INTL IN$2,305,000860,000
+100.0%
0.14%
PTIE NewPAIN THERAPEUTICS INC$2,186,0002,164,000
+100.0%
0.13%
DYNT BuyDYNATRONICS CORP$1,570,000
+0.8%
551,046
+1.8%
0.09%
-7.8%
APRI NewAPRICUS BIOSCIENCES INC$1,426,0004,600,000
+100.0%
0.09%
ONTX NewONCONOVA THERAPEUTICS INC$816,000111,216
+100.0%
0.05%
VXRT BuyVAXART INC$428,000
+82.1%
150,000
+93.3%
0.03%
+73.3%
RTTR BuyRITTER PHARMACEUTICALS INC$339,000
+841.7%
182,000
+1200.0%
0.02%
+900.0%
ROX NewCASTLE BRANDS INC$107,000100,000
+100.0%
0.01%
CTXR NewCITIUS PHARMACEUTICALS INC$100,00058,431
+100.0%
0.01%
TTNP NewTITAN PHARMACEUTICALS INC DE$46,000220,000
+100.0%
0.00%
ACHV ExitACHIEVE LIFE SCIENCE INC$0-62,000
-100.0%
-0.02%
ONTX ExitONCONOVA THERAPEUTICS INC$0-1,688,235
-100.0%
-0.04%
NOVN ExitNOVAN INC$0-500,000
-100.0%
-0.10%
CATB ExitCATABASIS PHARMACEUTICALS IN$0-2,000,000
-100.0%
-0.12%
STDY ExitSTEADYMED LTD$0-497,044
-100.0%
-0.15%
AMZN ExitAMAZON COM INC$0-2,000
-100.0%
-0.22%
IPCI ExitINTELLIPHARMACEUTICS INTL IN$0-8,600,000
-100.0%
-0.25%
ZOES ExitZOES KITCHEN INC$0-593,321
-100.0%
-0.38%
DSW ExitDSW INCcl a$0-280,000
-100.0%
-0.47%
CRSP ExitCRISPR THERAPEUTICS AGnamen akt$0-124,000
-100.0%
-0.48%
YELP ExitYELP INCcl a$0-200,000
-100.0%
-0.51%
DEPO ExitDEPOMED INC$0-1,177,900
-100.0%
-0.51%
PZZA ExitPAPA JOHNS INTL INC$0-250,000
-100.0%
-0.83%
APRN ExitBLUE APRON HLDGS INCcl a$0-4,000,000
-100.0%
-0.88%
ALXN ExitALEXION PHARMACEUTICALS INC$0-112,000
-100.0%
-0.91%
CELG ExitCELGENE CORP$0-175,000
-100.0%
-0.91%
EPC ExitEDGEWELL PERS CARE COcall$0-350,000
-100.0%
-1.15%
BGS ExitB & G FOODS INC NEW$0-700,000
-100.0%
-1.37%
SMPL ExitSIMPLY GOOD FOODS CO$0-1,460,000
-100.0%
-1.38%
TBPH ExitTHERAVANCE BIOPHARMA INC$0-1,180,000
-100.0%
-1.75%
FRPT ExitFRESHPET INCcall$0-1,000,000
-100.0%
-1.79%
INCY ExitINCYTE CORP$0-428,000
-100.0%
-1.87%
SEAS ExitSEAWORLD ENTMT INC$0-1,576,000
-100.0%
-2.25%
PZZA ExitPAPA JOHNS INTL INCcall$0-750,000
-100.0%
-2.48%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings